Balance Sheet HCA Healthcare, Inc.

Equities

HCA

US40412C1018

Healthcare Facilities & Services

Market Closed - Nyse Other stock markets 01:30:02 06/06/2026 am IST			5-day change	1st Jan Change
372.13 ^USD	+2.85%		-1.69%	-20.29%

04/06	Bernstein Adjusts Price Target on HCA Healthcare to $413 From $503, Maintains Market Perform Rating	MT
28/05	HCA Healthcare Agrees to Buy The College of Health Care Professions	DJ

07df.Y6Cj7GcFAydzWwrV2yiUCFMT2Kl3_1z_ZazTpDZaZ_A.KvPog1RhWRQebl3g6mbdeQNEj-AguTmRIfWUxXNsVINb5OS5H2F6QB81ZQ

Published financial data: HCA HEALTHCARE, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	5.88TCr	6.02TCr	6.5TCr	7.06TCr	7.56TCr
Total Revenues	5.88TCr	6.02TCr	6.5TCr	7.06TCr	7.56TCr
Cost of Goods Sold, Total	3.63TCr	3.71TCr	3.94TCr	4.19TCr	4.42TCr
Gross Profit	2.25TCr	2.32TCr	2.56TCr	2.87TCr	3.14TCr
Selling General & Admin Expenses, Total	99Cr	98Cr	99Cr	104.9Cr	103Cr
Depreciation & Amortization - (IS)	285.3Cr	296.9Cr	307.7Cr	331.2Cr	352.3Cr
Other Operating Expenses	897.2Cr	1.02TCr	1.19TCr	1.38TCr	1.49TCr
Other Operating Expenses, Total	1.28TCr	1.41TCr	1.6TCr	1.81TCr	1.94TCr
Operating Income	967.8Cr	905.3Cr	962.7Cr	1.05TCr	1.2TCr
Interest Expense, Total	-156.6Cr	-174.1Cr	-193.8Cr	-206.1Cr	-224.8Cr
Net Interest Expenses	-156.6Cr	-174.1Cr	-193.8Cr	-206.1Cr	-224.8Cr
Income (Loss) On Equity Invest.	11Cr	4.5Cr	2.2Cr	2.3Cr	7.8Cr
EBT, Excl. Unusual Items	822.5Cr	735.7Cr	771.1Cr	850.9Cr	979.5Cr
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	162Cr	130.1Cr	-50L	1.4Cr	3.7Cr
Legal Settlements	-	-	-	-	-
Other Unusual Items	-1.2Cr	-7.8Cr	-	-	-
EBT, Incl. Unusual Items	983.3Cr	858Cr	770.6Cr	852.3Cr	983.2Cr
Income Tax Expense	211.2Cr	174.6Cr	161.5Cr	186.6Cr	205Cr
Earnings From Continuing Operations	772.1Cr	683.4Cr	609.1Cr	665.7Cr	778.2Cr
Net Income to Company	772.1Cr	683.4Cr	609.1Cr	665.7Cr	778.2Cr
Minority Interest	-76Cr	-119.1Cr	-85Cr	-90Cr	-100Cr
Net Income - (IS)	695.6Cr	564.3Cr	524.2Cr	576Cr	678.4Cr
Net Income to Common Incl Extra Items	695.6Cr	564.3Cr	524.2Cr	576Cr	678.4Cr
Net Income to Common Excl. Extra Items	695.6Cr	564.3Cr	524.2Cr	576Cr	678.4Cr
Per Share Items
Net EPS - Basic	21.51	19.44	19.24	22.27	28.7
Basic EPS - Continuing Operations	21.51	19.44	19.24	22.27	28.7
Basic Weighted Average Shares Outstanding	32Cr	29Cr	27Cr	26Cr	24Cr
Net EPS - Diluted	21.16	19.15	18.97	22	28.33
Diluted EPS - Continuing Operations	21.16	19.15	18.97	22	28.33
Diluted Weighted Average Shares Outstanding	33Cr	29Cr	28Cr	26Cr	24Cr
Normalized Basic EPS	13.53	11.73	14.58	17.1	21.67
Normalized Diluted EPS	13.31	11.56	14.36	16.89	21.39
Dividend Per Share	1.92	2.24	2.4	2.64	2.88
Payout Ratio	8.97	11.57	12.61	11.98	10.01
American Depositary Receipts Ratio (ADR)	0.05	0.05	0.05	0.05	0.05
Supplemental Items
EBITDA	1.25TCr	1.2TCr	1.27TCr	1.39TCr	1.55TCr
EBITA	970.3Cr	909.7Cr	964.7Cr	1.06TCr	1.2TCr
EBIT	967.8Cr	905.3Cr	962.7Cr	1.05TCr	1.2TCr
EBITDAR	1.35TCr	1.3TCr	1.37TCr	1.49TCr	1.65TCr
Total Revenues (As Reported)	-	-	-	-	-
Effective Tax Rate - (Ratio)	21.48	20.35	20.96	21.89	20.85
Current Domestic Taxes	208Cr	142.8Cr	133.1Cr	141.4Cr	179.9Cr
Current Foreign Taxes	1.5Cr	1.8Cr	30L	2Cr	1.3Cr
Total Current Taxes	209.5Cr	144.6Cr	133.4Cr	143.4Cr	181.2Cr
Deferred Domestic Taxes	60L	29Cr	26Cr	42Cr	23Cr
Deferred Foreign Taxes	1.1Cr	1.2Cr	1.9Cr	70L	60L
Total Deferred Taxes	1.7Cr	30Cr	28Cr	43Cr	24Cr
Normalized Net Income	437.56Cr	340.71Cr	397.04Cr	442.11Cr	512.39Cr
Interest on Long-Term Debt	156.6Cr	174.1Cr	193.8Cr	206.1Cr	4.1Cr
Non-Cash Pension Expense	6.4Cr	-1.6Cr	5.2Cr	3.2Cr	4.1Cr
Supplemental Operating Expense Items
Net Rental Expense, Total	99Cr	98Cr	99Cr	104.9Cr	103Cr
Imputed Operating Lease Interest Expense	35Cr	35Cr	38Cr	40Cr	39Cr
Imputed Operating Lease Depreciation	63Cr	62Cr	62Cr	65Cr	64Cr
Stock-Based Comp., COGS (Total)	44Cr	34Cr	26Cr	36Cr	40Cr
Total Stock-Based Compensation	44Cr	34Cr	26Cr	36Cr	40Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	145.1Cr	91Cr	94Cr	193.3Cr	104Cr
Short Term Investments	10Cr	9.2Cr	8.7Cr	8.8Cr	10Cr
Total Cash And Short Term Investments	155.4Cr	100Cr	102.2Cr	202.1Cr	114.3Cr
Accounts Receivable, Total	810.6Cr	890.3Cr	996.6Cr	1.08TCr	1.09TCr
Total Receivables	810.6Cr	890.3Cr	996.6Cr	1.08TCr	1.09TCr
Inventory	198.6Cr	206.8Cr	202.1Cr	173.8Cr	165.2Cr
Other Current Assets, Total	189.6Cr	167.2Cr	191.8Cr	185.9Cr	211.2Cr
Total Current Assets	1.35TCr	1.36TCr	1.49TCr	1.64TCr	1.58TCr
Gross Property Plant And Equipment	5.35TCr	5.68TCr	6.08TCr	6.46TCr	6.84TCr
Accumulated Depreciation	-2.73TCr	-2.92TCr	-3.08TCr	-3.31TCr	-3.51TCr
Net Property Plant And Equipment	2.62TCr	2.76TCr	2.99TCr	3.15TCr	3.33TCr
Long-term Investments	89Cr	120.4Cr	123.3Cr	123.1Cr	111.8Cr
Goodwill	913.7Cr	929.4Cr	960.6Cr	977Cr	998.2Cr
Other Intangibles, Total	40Cr	36Cr	34Cr	32Cr	31Cr
Accounts Receivable Long-Term	4.4Cr	4.8Cr	3.4Cr	3.5Cr	3.8Cr
Other Long-Term Assets, Total	55Cr	25Cr	15Cr	20Cr	22Cr
Total Assets	5.07TCr	5.24TCr	5.62TCr	5.95TCr	6.07TCr
Liabilities
Accounts Payable, Total	411.1Cr	423.9Cr	423.3Cr	427.6Cr	465.9Cr
Accrued Expenses, Total	424.7Cr	433.3Cr	510.3Cr	527.3Cr	587.2Cr
Short-term Borrowings	-	-	-	-	220.7Cr
Current Portion of Long-Term Debt	10Cr	24Cr	225.8Cr	453.6Cr	254.9Cr
Current Portion of Leases	54Cr	50Cr	53Cr	50Cr	48Cr
Other Current Liabilities	59Cr	60Cr	53Cr	59Cr	58Cr
Total Current Liabilities	958.2Cr	990.2Cr	1.27TCr	1.52TCr	1.64TCr
Long-Term Debt	3.38TCr	3.71TCr	3.66TCr	3.77TCr	4.1TCr
Long-Term Leases	233.2Cr	233.1Cr	244.4Cr	248.7Cr	247.8Cr
Other Non Current Liabilities	357.4Cr	314.3Cr	342.4Cr	358.5Cr	368.5Cr
Total Liabilities	4.93TCr	5.25TCr	5.52TCr	5.9TCr	6.35TCr
Common Stock, Total	30L	30L	30L	30L	20L
Additional Paid In Capital	-	-	-	-	-
Retained Earnings	-53Cr	-228Cr	-135.2Cr	-211.5Cr	-572.4Cr
Comprehensive Income and Other	-40Cr	-49Cr	-42Cr	-39Cr	-30Cr
Total Common Equity	-93Cr	-276.7Cr	-177.4Cr	-249.9Cr	-602.7Cr
Minority Interest	242.2Cr	269.4Cr	283.4Cr	305.4Cr	325.6Cr
Total Equity	148.9Cr	-7.3Cr	106Cr	56Cr	-277.1Cr
Total Liabilities And Equity	5.07TCr	5.24TCr	5.62TCr	5.95TCr	6.07TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	30Cr	28Cr	26Cr	25Cr	22Cr
ECS Total Common Shares Outstanding	31Cr	28Cr	27Cr	25Cr	22Cr
Book Value / Share	-3.05	-9.98	-6.68	-10	-26.83
Tangible Book Value	-1.05TCr	-1.24TCr	-1.17TCr	-1.26TCr	-1.63TCr
Tangible Book Value Per Share	-34.28	-44.78	-44.13	-50.37	-72.66
Total Debt	3.67TCr	4.02TCr	4.19TCr	4.52TCr	4.87TCr
Net Debt	3.52TCr	3.92TCr	4.08TCr	4.32TCr	4.76TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	46Cr	35Cr	33Cr	34Cr	36Cr
Debt Equivalent Oper. Leases	791.2Cr	780.8Cr	795.2Cr	839.2Cr	824Cr
Minority Interest, Total (Incl. Fin. Div)	242.2Cr	269.4Cr	283.4Cr	305.4Cr	325.6Cr
Equity Method Investments, Total	45Cr	82Cr	76Cr	66Cr	63Cr
Account Code - Inventory Valuation	5	5	5	5	5
Land - (BS)	249.6Cr	279.9Cr	312Cr	329.5Cr	341.5Cr
Buildings, Total	1.92TCr	2.02TCr	2.16TCr	2.27TCr	2.37TCr
Machinery, Total	2.83TCr	3TCr	3.2TCr	3.47TCr	3.7TCr
Full Time Employees	2L	2L	2L	2L	2L
Part Time Employees	80T	87T	90T	90T	90T
Accumulated Allowance for Doubtful Accounts (Supple)	678.4Cr	678Cr	728.3Cr	777.3Cr	767.4Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	695.6Cr	564.3Cr	524.2Cr	576Cr	678.4Cr
Depreciation & Amortization - CF	282.8Cr	292.5Cr	305.7Cr	329.6Cr	351.1Cr
Amortization of Goodwill and Intangible Assets - (CF)	2.5Cr	4.4Cr	2Cr	1.6Cr	1.2Cr
Depreciation & Amortization, Total	285.3Cr	296.9Cr	307.7Cr	331.2Cr	352.3Cr
Amortization of Deferred Charges, Total - (CF)	2.7Cr	2.9Cr	3.5Cr	3.5Cr	4.4Cr
(Gain) Loss From Sale Of Asset	-162Cr	-130.1Cr	50L	-1.4Cr	-3.7Cr
Stock-Based Compensation (CF)	44Cr	34Cr	26Cr	36Cr	40Cr
Other Operating Activities, Total	81Cr	199.3Cr	126.7Cr	116.7Cr	150.3Cr
Change In Accounts Receivable	-96Cr	-80Cr	-94Cr	-80Cr	-9.4Cr
Change In Inventories	-54Cr	-5.9Cr	-13Cr	33Cr	-15Cr
Change In Accounts Payable	100Cr	-30Cr	60Cr	36Cr	67Cr
Change in Other Net Operating Assets	-	-	-	-	-
Cash from Operations	895.9Cr	852.2Cr	943.1Cr	1.05TCr	1.26TCr
Capital Expenditure	-357.7Cr	-439.5Cr	-474.4Cr	-487.5Cr	-494.4Cr
Cash Acquisitions	-110.5Cr	-22Cr	-64Cr	-27Cr	-40Cr
Divestitures	216Cr	123.7Cr	19Cr	33Cr	27Cr
Investment in Marketable and Equity Securities, Total	-12Cr	1.4Cr	-11Cr	-12Cr	7.2Cr
Other Investing Activities, Total	-40L	-2.1Cr	-1.9Cr	-50L	1.2Cr
Cash from Investing	-264.3Cr	-338.9Cr	-531.7Cr	-493.3Cr	-498.8Cr
Long-Term Debt Issued, Total	712.4Cr	611.7Cr	322.4Cr	749.5Cr	1.07TCr
Total Debt Issued	712.4Cr	611.7Cr	322.4Cr	749.5Cr	1.07TCr
Long-Term Debt Repaid, Total	-386.9Cr	-283Cr	-192.9Cr	-429Cr	-738.9Cr
Total Debt Repaid	-386.9Cr	-283Cr	-192.9Cr	-429Cr	-738.9Cr
Repurchase of Common Stock	-821.5Cr	-700Cr	-381.1Cr	-604.2Cr	-1.01TCr
Common Dividends Paid	-62Cr	-65Cr	-66Cr	-69Cr	-68Cr
Common & Preferred Stock Dividends Paid	-62Cr	-65Cr	-66Cr	-69Cr	-68Cr
Other Financing Activities, Total	-107.1Cr	-129Cr	-92Cr	-105.5Cr	-109.1Cr
Cash from Financing	-665.5Cr	-565.6Cr	-409.4Cr	-458.2Cr	-855Cr
Foreign Exchange Rate Adjustments	-30L	-2Cr	70L	-10L	90L
Net Change in Cash	-34Cr	-54Cr	2.7Cr	100Cr	-89Cr
Supplemental Items
Cash Interest Paid	150.2Cr	166.2Cr	189.2Cr	193.8Cr	220.7Cr
Cash Income Tax Paid (Refund)	218.2Cr	117.5Cr	138.6Cr	184.4Cr	174Cr
Levered Free Cash Flow	407.8Cr	308.2Cr	287.36Cr	391.58Cr	582.31Cr
Unlevered Free Cash Flow	502.98Cr	414.11Cr	404.99Cr	516.89Cr	718.41Cr
Change In Net Working Capital	74Cr	43Cr	56Cr	22Cr	-73Cr
Net Debt Issued / Repaid	325.5Cr	328.7Cr	129.5Cr	320.5Cr	328.7Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	12.32	10.97	11.08	11.39	12.44
Return on Total Capital	16.3	14.44	14.49	14.86	16.31
Return On Equity %	352.48	965.25	1.23T	824.4	-702.35
Return on Common Equity	-3.85T	-305.03	-230.87	-269.6	-159.14
Margin Analysis
Gross Profit Margin %	38.28	38.48	39.37	40.62	41.5
SG&A Margin	1.68	1.62	1.53	1.49	1.36
EBITDA Margin %	21.33	19.96	19.55	19.63	20.49
EBITA Margin %	16.52	15.1	14.85	14.96	15.84
EBIT Margin %	16.47	15.03	14.82	14.94	15.83
Income From Continuing Operations Margin %	13.14	11.35	9.38	9.43	10.29
Net Income Margin %	11.84	9.37	8.07	8.16	8.97
Net Avail. For Common Margin %	11.84	9.37	8.07	8.16	8.97
Normalized Net Income Margin	7.45	5.66	6.11	6.26	6.78
Levered Free Cash Flow Margin	6.94	5.12	4.42	5.55	7.7
Unlevered Free Cash Flow Margin	8.56	6.88	6.23	7.32	9.5
Asset Turnover
Asset Turnover	1.2	1.17	1.2	1.22	1.26
Fixed Assets Turnover	2.29	2.24	2.26	2.3	2.33
Receivables Turnover (Average Receivables)	7.75	7.08	6.89	6.8	6.98
Inventory Turnover (Average Inventory)	18.08	18.28	19.27	22.31	26.09
Short Term Liquidity
Current Ratio	1.41	1.38	1.18	1.08	0.97
Quick Ratio	1.01	1	0.87	0.84	0.74
Operating Cash Flow to Current Liabilities	0.93	0.86	0.75	0.69	0.77
Days Sales Outstanding (Average Receivables)	47.11	51.54	53	53.81	52.32
Days Outstanding Inventory (Average Inventory)	20.19	19.97	18.95	16.41	13.99
Average Days Payable Outstanding	38.52	41.03	39.3	37.39	36.94
Cash Conversion Cycle (Average Days)	28.77	30.47	32.65	32.83	29.36
Long Term Solvency
Total Debt/Equity	2.47T	-55.07T	3.95T	8.15T	-1.76T
Total Debt / Total Capital	96.1	100.18	97.53	98.79	106.03
LT Debt/Equity	2.42T	-54.06T	3.69T	7.24T	-1.57T
Long-Term Debt / Total Capital	94.44	98.35	91.04	87.78	94.62
Total Liabilities / Total Assets	97.07	100.14	98.11	99.07	104.56
EBIT / Interest Expense	6.18	5.2	4.97	5.12	5.32
EBITDA / Interest Expense	8.63	7.47	7.07	7.23	7.35
(EBITDA - Capex) / Interest Expense	6.35	4.94	4.62	4.87	5.15
Total Debt / EBITDA	2.72	3.09	3.06	3.03	2.95
Net Debt / EBITDA	2.6	3.02	2.98	2.9	2.88
Total Debt / (EBITDA - Capex)	3.69	4.67	4.67	4.51	4.21
Net Debt / (EBITDA - Capex)	3.54	4.56	4.56	4.31	4.11
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.01	2.52	7.86	8.67	7.08
Gross Profit, 1 Yr. Growth %	16.6	3.05	10.36	12.12	9.4
EBITDA, 1 Yr. Growth %	25.52	-4.06	5.67	9.1	11.75
EBITA, 1 Yr. Growth %	33.14	-6.25	6.05	9.51	13.39
EBIT, 1 Yr. Growth %	33.27	-6.46	6.34	9.57	13.44
Earnings From Cont. Operations, 1 Yr. Growth %	76	-11.49	-10.87	9.29	16.9
Net Income, 1 Yr. Growth %	85.3	-18.88	-7.11	9.88	17.78
Normalized Net Income, 1 Yr. Growth %	48.35	-22.13	16.53	11.37	15.9
Diluted EPS Before Extra, 1 Yr. Growth %	93.6	-9.5	-0.94	15.97	28.77
Accounts Receivable, 1 Yr. Growth %	14.83	9.83	11.94	8.33	0.74
Inventory, 1 Yr. Growth %	-1.93	4.13	-2.27	-14	-4.95
Net Property, Plant and Equip., 1 Yr. Growth %	3.78	5.59	8.26	5.42	5.47
Total Assets, 1 Yr. Growth %	6.85	3.34	7.2	5.87	2.03
Tangible Book Value, 1 Yr. Growth %	30.81	18.59	-5.64	7.45	29.61
Common Equity, 1 Yr. Growth %	-263.11	196.57	-35.89	40.87	141.18
Cash From Operations, 1 Yr. Growth %	-2.96	-4.88	10.67	11.48	20.18
Capital Expenditures, 1 Yr. Growth %	26.17	22.87	7.94	2.76	1.42
Levered Free Cash Flow, 1 Yr. Growth %	-12.95	-24.42	-6.76	36.29	48.71
Unlevered Free Cash Flow, 1 Yr. Growth %	-10.9	-17.67	-2.2	27.65	38.99
Dividend Per Share, 1 Yr. Growth %	346.51	16.67	7.14	10	9.09
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	6.98	8.11	5.16	8.27	7.87
Gross Profit, 2 Yr. CAGR %	7.97	9.61	6.64	11.24	10.75
EBITDA, 2 Yr. CAGR %	13	9.74	0.69	7.36	10.42
EBITA, 2 Yr. CAGR %	15.94	11.92	-0.16	8.01	11.55
EBIT, 2 Yr. CAGR %	15.79	11.65	-0.26	7.93	11.49
Earnings From Cont. Operations, 2 Yr. CAGR %	36.48	24.81	-11.18	-1.3	13.03
Net Income, 2 Yr. CAGR %	40.88	22.6	-13.19	1.03	13.76
Normalized Net Income, 2 Yr. CAGR %	25.95	7.48	-4.74	13.9	13.61
Diluted EPS Before Extra, 2 Yr. CAGR %	44.96	32.37	-5.32	7.18	22.21
Accounts Receivable, 2 Yr. CAGR %	4.74	12.3	10.88	10.12	4.47
Inventory, 2 Yr. CAGR %	3.64	1.06	0.88	-8.33	-9.59
Net Property, Plant and Equip., 2 Yr. CAGR %	3.26	4.68	6.92	6.83	5.45
Total Assets, 2 Yr. CAGR %	6.12	5.08	5.25	6.53	3.93
Tangible Book Value, 2 Yr. CAGR %	-2.76	24.55	5.78	0.69	18.01
Common Equity, 2 Yr. CAGR %	-42.36	119.94	37.89	-4.97	84.32
Cash From Operations, 2 Yr. CAGR %	8.56	-3.92	2.6	11.07	15.75
Capital Expenditures, 2 Yr. CAGR %	-7.25	24.51	15.16	5.32	2.09
Levered Free Cash Flow, 2 Yr. CAGR %	46.38	-18.89	-16.06	12.71	42.37
Unlevered Free Cash Flow, 2 Yr. CAGR %	29.2	-14.35	-10.27	11.71	33.2
Dividend Per Share, 2 Yr. CAGR %	9.54	128.24	11.8	8.56	9.54
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	7.97	5.47	8.03	6.32	7.87
Gross Profit, 3 Yr. CAGR %	8.67	6.3	9.86	8.44	10.62
EBITDA, 3 Yr. CAGR %	12	7	8.37	3.41	8.81
EBITA, 3 Yr. CAGR %	13.47	8.02	9.93	2.96	9.77
EBIT, 3 Yr. CAGR %	13.37	7.84	9.85	2.91	9.74
Earnings From Cont. Operations, 3 Yr. CAGR %	20.72	18.14	11.56	-4.82	4.43
Net Income, 3 Yr. CAGR %	22.47	17.2	11.77	-6.1	6.33
Normalized Net Income, 3 Yr. CAGR %	20.99	7.3	10.41	0.35	14.56
Diluted EPS Before Extra, 3 Yr. CAGR %	25.68	23.89	20.18	1.31	13.94
Accounts Receivable, 3 Yr. CAGR %	6.04	6.41	12.18	10.02	6.9
Inventory, 3 Yr. CAGR %	4.67	3.8	-0.07	-4.35	-7.21
Net Property, Plant and Equip., 3 Yr. CAGR %	9.83	4.03	5.86	6.42	6.38
Total Assets, 3 Yr. CAGR %	8.98	5.19	5.78	5.46	5.01
Tangible Book Value, 3 Yr. CAGR %	-6.72	3.89	13.54	6.33	9.53
Common Equity, 3 Yr. CAGR %	-42.66	-0.49	45.83	38.88	29.63
Cash From Operations, 3 Yr. CAGR %	9.84	3.88	0.71	5.48	14.03
Capital Expenditures, 3 Yr. CAGR %	0.04	1.86	18.72	10.87	4
Levered Free Cash Flow, 3 Yr. CAGR %	19.19	17.43	-15.03	-1.34	23.62
Unlevered Free Cash Flow, 3 Yr. CAGR %	13.13	11.18	-10.48	0.91	20.15
Dividend Per Share, 3 Yr. CAGR %	11.1	11.87	77.38	11.2	8.74
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	7.21	6.67	6.84	6.58	7.97
Gross Profit, 5 Yr. CAGR %	7.51	7.37	7.85	8.25	10.22
EBITDA, 5 Yr. CAGR %	8.95	7.99	7.33	7.15	9.18
EBITA, 5 Yr. CAGR %	9.38	8.48	7.75	7.91	10.52
EBIT, 5 Yr. CAGR %	9.32	8.38	7.71	7.88	10.5
Earnings From Cont. Operations, 5 Yr. CAGR %	17.6	20.03	6.77	9.94	12.15
Net Income, 5 Yr. CAGR %	19.2	20.56	6.72	10.45	12.56
Normalized Net Income, 5 Yr. CAGR %	13.74	8.85	9.95	9.9	11.68
Diluted EPS Before Extra, 5 Yr. CAGR %	23.72	26.34	12.22	16.92	20.98
Accounts Receivable, 5 Yr. CAGR %	6.8	6.47	7.95	7.88	9.03
Inventory, 5 Yr. CAGR %	5.73	5.62	3.13	-1.23	-3.99
Net Property, Plant and Equip., 5 Yr. CAGR %	9.87	9.08	8.66	5.14	5.69
Total Assets, 5 Yr. CAGR %	8.49	7.46	7.47	5.72	5.04
Tangible Book Value, 5 Yr. CAGR %	-5.65	-2.64	-1.91	2.6	15.31
Common Equity, 5 Yr. CAGR %	-33.73	-16.47	-18.55	-2.3	60.16
Cash From Operations, 5 Yr. CAGR %	9.65	9.45	6.88	6.7	6.48
Capital Expenditures, 5 Yr. CAGR %	5.32	7.83	5.83	3.23	11.76
Levered Free Cash Flow, 5 Yr. CAGR %	8.74	12.83	3.6	15.52	4.45
Unlevered Free Cash Flow, 5 Yr. CAGR %	6.24	8.85	3.11	11.4	4.94
Dividend Per Share, 5 Yr. CAGR %	-	-	11.38	10.53	46.28